It is now clear that aging can be delayed, at least in mice, either by genetic mutations, or very low calorie diets, or, most recently, by adding drugs to the food. Professor Miller will explain why and provide a perspective on the obstacles - largely social and political - that are delaying the translations of these laboratory findings to the realm of human preventative medicine.
Richard A. Miller, M.D., Ph.D., is a Professor of Pathology at the University of Michigan, and the Director of Michigan's Paul F. Glenn Center for Biology of Aging Research. He received the BA degree in 1971 from Haverford College, and MD and PhD degrees from Yale University in 1976-1977. After postdoctoral studies at Harvard and Sloan-Kettering, he moved to Boston University in 1982 and then to his current position at Michigan in 1990. Dr. Miller has served in a variety of editorial and advisory positions on behalf of the American Federation for Aging Research and the National Institute on Aging, and served as one of the Editors-in-Chief of Aging Cell. He is the recipient of the Nathan Shock Award, the AlliedSignal Award, the Irving Wright Award, an award from the Glenn Foundation, and the Kleemeier Award for aging research, and was a Senior Scholar of the Ellison Medical Foundation. He is a Fellow of the American Association for the Advancement of Science, and a Member of the Association of American Physicians. At Michigan, he directs the Geriatrics Center's Biogerontology program, and the Paul F. Glenn Center for Aging Research. His research program includes ongoing studies of the mechanisms that link stress, nutrients, and hormones to delayed aging in mice, and works to develop new approaches to slow aging and disease through drugs, early life dietary restriction, and targeted mutations. He also studies the ways in which cells from long-lived birds, rodents, and primates may differ from those of short-lived species.